Search

Geron Corp

Gesloten

SectorGezondheidszorg

1.26 0.8

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.24

Max

1.26

Belangrijke statistieken

By Trading Economics

Inkomsten

-13M

-17M

Verkoop

5.6M

57M

EPS

-0.02

Winstmarge

-29.019

Werknemers

258

EBITDA

-16M

-12M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+243.92% upside

Dividenden

By Acuity

Volgende Winsten

4 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

14M

835M

Vorige openingsprijs

0.46

Vorige sluitingsprijs

1.26

Geron Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 sep 2026, 19:46 UTC

Geron Corp is trading higher, having peaked earlier before retracing, though it remains below its 20-day moving average amid broader market weakness.

24 sep 2026, 20:07 UTC

Geron Corp is advancing during Thursday's trading session, having peaked in the mid-afternoon, although it remains below its 20-day moving average.

23 sep 2026, 22:01 UTC

In after-market trading, Geron Corp has advanced notably, moving higher since Wednesday's close, despite being 11.49% below its 20-day moving average.

22 sep 2026, 22:50 UTC

Geron Corp is advancing in after-market trading, recovering from earlier declines, though it remains below its 20-day moving average.

18 sep 2026, 19:36 UTC

Geron Corp shares fell sharply, continuing a decline since Thursday and trading significantly below the 20-day moving average.

17 sep 2026, 23:01 UTC

Geron Corp's shares rose in after-market trading, recovering from earlier losses to reach their highest level of the day since Thursday's close.

16 sep 2026, 20:10 UTC

Geron Corp's shares fell sharply, continuing a decline from Tuesday and trading near the lower end of its one-month range.

15 sep 2026, 23:11 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Tuesday's close and about 11.99% below the 20-day moving average.

10 sep 2026, 20:06 UTC

Geron Corp shares are lower today, continuing a trend of four consecutive sessions of declines amid a broader market downturn.

9 sep 2026, 20:01 UTC

Geron Corp's shares are trading lower amid broader market declines, nearing the bottom of their one-month range and below the 20-day moving average.

8 sep 2026, 20:07 UTC

Geron Corp's shares are lower today, continuing a downward trend since Friday amid broader market pressure linked to interest rate hike speculation.

3 sep 2026, 20:07 UTC

Geron Corp's shares are lower during Thursday's session amid broader market declines, with no specific company news identified to explain the movement.

2 sep 2026, 23:06 UTC

Geron Corp shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 sep 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting a positive move since Tuesday's close amid broader market fluctuations. No specific news was identified.

31 aug 2026, 23:01 UTC

Geron Corp shares are higher in after-market trading, following notable volatility. The stock's movement contrasts with recent lower closes over the past four sessions.

28 aug 2026, 19:46 UTC

Geron Corp shares are lower today, continuing a three-day decline amid ongoing inflation concerns and recent comments from Fed officials on price stability.

27 aug 2026, 23:01 UTC

Geron Corp traded roughly flat in after-market hours, remaining effectively unchanged since Thursday's close, with stability indicated by its position above the 20-day moving average.

26 aug 2026, 19:56 UTC

Geron Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains above its 20-day moving average.

25 aug 2026, 21:51 UTC

Geron Corp shares declined after market hours, reflecting broader trends amid a sharp drop in crude oil prices. The stock remains near its one-month range high.

24 aug 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

21 aug 2026, 19:46 UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

20 aug 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, showing notable volatility while remaining above their 20-day moving average and near the month's upper range.

19 aug 2026, 19:26 UTC

Geron Corp shares are higher today, continuing a three-day upward trend. The stock remains above its 20-day moving average, indicating strong market positioning.

18 aug 2026, 21:03 UTC

News

Geron Corporation's shares are lower in after-market trading following the grant of stock options to new employees at an exercise price of $1.53.

17 aug 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

14 aug 2026, 20:02 UTC

Macro Event

Geron Corp shares are lower today amid broader market declines and disappointing U.S. retail sales data, reflecting negative investor sentiment.

13 aug 2026, 23:36 UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

12 aug 2026, 23:36 UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

11 aug 2026, 22:52 UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

10 aug 2026, 23:06 UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

Peer Vergelijking

Prijswijziging

Geron Corp Prognose

Koersdoel

By TipRanks

243.92% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.333 USD  243.92%

Hoogste 6 USD

Laagste 3 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Geron Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.